ACE2 and nonpapillary renal cell carcinoma: Nevertheless, our study is the first to determine the clinical roles of ACE2 in ccRCC through various databases and laboratory experiments, and these findings may contribute to a better understanding of the impact of COVID-19 on ccRCC patients.